Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-agent gemcitabine in patients with resistant small-cell lung cancer.
van der Lee I, Smit EF, van Putten JW, Groen HJ, Schlösser NJ, Postmus PE, Schramel FM. van der Lee I, et al. Among authors: van putten jw. Ann Oncol. 2001 Apr;12(4):557-61. doi: 10.1023/a:1011104509759. Ann Oncol. 2001. PMID: 11398892 Free article. Clinical Trial.
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.
Biesma B, Wymenga ANM, Vincent A, Dalesio O, Smit HJM, Stigt JA, Smit EF, van Felius CL, van Putten JWG, Slaets JPJ, Groen HJM; Dutch Chest Physician Study Group. Biesma B, et al. Ann Oncol. 2011 Jul;22(7):1520-1527. doi: 10.1093/annonc/mdq637. Epub 2011 Jan 20. Ann Oncol. 2011. PMID: 21252061 Free article. Clinical Trial.
Iris metastasis in small-cell lung carcinoma.
Roenhorst AW, van den Bergh AC, van Putten JW, Smit EF. Roenhorst AW, et al. Among authors: van den bergh ac, van putten jw. J Thorac Oncol. 2007 Dec;2(12):1128-9. doi: 10.1097/JTO.0b013e31815ba210. J Thorac Oncol. 2007. PMID: 18090588 Free article.
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study.
Groen HJ, van der Leest AH, Fokkema E, Timmer PR, Nossent GD, Smit WJ, Nabers J, Hoekstra HJ, Hermans J, Otter R, van Putten JW, de Vries EG, Mulder NH. Groen HJ, et al. Among authors: van der leest ah, van putten jw. Ann Oncol. 2004 Mar;15(3):427-32. doi: 10.1093/annonc/mdh100. Ann Oncol. 2004. PMID: 14998844 Free article. Clinical Trial.
44 results